Abercrombie & Fitch Company
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Abercrombie & Fitch Company.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 65.60 $ to 152.10 $ · Last price: 135.80 $ (As of: September 18, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Apparel Retail
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Abercrombie & Fitch Company ANF | 6.2 | 13.6 | 6.9 | 63.7 | 8.0 | 6.4 | 62.3 |
| The TJX Companies Inc TJX | 140.5 | 25.3 | 15.6 | 31.5 | 11.8 | 7.1 | -8.0 |
| Ross Stores Inc ROST | 72.7 | 32.2 | 18.2 | 33.4 | 13.4 | 7.7 | 56.4 |
| Burlington Stores Inc BURL | 14.9 | 26.1 | 13.5 | 44.1 | 5.9 | 8.8 | -8.9 |
| Lululemon Athletica Inc. LULU | 11.1 | 8.4 | 4.7 | 54.9 | 11.2 | 4.9 | -39.2 |
| The Gap, Inc. GAP | 7.5 | 8.4 | 4.5 | 40.5 | 12.7 | 1.9 | -5.7 |
| Urban Outfitters Inc URBN | 6.6 | 15.7 | 8.1 | 36.0 | 9.0 | 11.1 | 8.2 |
| Victoria's Secret & Co VSXY | 6.2 | 31.5 | 10.9 | 37.8 | 5.2 | 5.2 | – |
| Boot Barn Holdings Inc BOOT | 3.8 | 17.1 | 11.2 | 37.8 | 10.6 | 17.9 | -31.4 |
| Median of companies shown | 7.5 | 17.1 | 10.9 | 37.8 | 10.6 | 7.1 | -6.8 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | 3,327 | 15 | 4 | 0.06 | 185 | 1,243 | 2,296 |
| 2018 | 3,493 | 72 | 7 | 0.10 | 288 | 1,242 | 2,326 |
| 2019 | 3,590 | 127 | 75 | 1.08 | 353 | 1,219 | 2,386 |
| 2020 | 3,623 | 70 | 39 | 0.60 | 301 | 1,059 | 3,550 |
| 2021 | 3,125 | -20 | -114 | -1.82 | 405 | 937 | 3,315 |
| 2022 | 3,713 | 343 | 263 | 4.20 | 278 | 826 | 2,939 |
| 2023 | 3,698 | 93 | 3 | 0.05 | -2 | 695 | 2,713 |
| 2024 | 4,281 | 485 | 328 | 6.22 | 653 | 1,035 | 2,974 |
| 2025 | 4,949 | 741 | 566 | 10.69 | 710 | 1,336 | 3,300 |
| 2026 | 5,266 | 699 | 507 | 10.46 | 619 | 1,404 | 3,542 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2025: Q1 | 3.57 | 20.30 | 1,585 | 9.10 | 11.80 | 308 | 257 |
| 2025: Q2 | 1.59 | -25.70 | 1,097 | 7.50 | 7.30 | -4 | -55 |
| 2025: Q3 | 2.91 | 16.50 | 1,209 | 6.60 | 11.70 | 117 | 51 |
| 2025: Q4 | 2.36 | -5.50 | 1,291 | 6.80 | 8.80 | 200 | 132 |
| 2026: Q1 | 3.68 | 3.00 | 1,670 | 5.40 | 10.30 | 306 | 251 |
| 2026: Q2 | 1.47 | -7.50 | 1,114 | 1.50 | 6.00 | 44 | -17 |
| 2026: Q3 | 4.17 | 43.30 | 1,267 | 4.80 | 14.50 | 269 | 201 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 3 of our scanner strategies — each hit links to the scanner.
Backtested Scanners
Quality & Balance Sheet
Momentum & Trend
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 01/31/2027 | 13.54 | 13.20 – 13.76 | 5,529 | 37.3% | 6 |
| 01/31/2028 | 13.18 | 11.57 – 14.20 | 5,769 | -5.2% | 7 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly -0.7% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $566.5M |
|---|---|
| Market cap | $6.16B |
| Free cash flow in year ten | $528.9M |
| Terminal value as a share of market value | 45.3% |
For comparison: over the past five years free cash flow grew by 4.5% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 12.5%
- More than 10% revenue growth is expected for the coming year 3.7%
- Share count grows by less than 3% a year -2.5%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 13.6%
- Gross margin at 40% or higher and without meaningful erosion 61.5%
- Goodwill from acquisitions does not grow faster than revenue 0.0%
- Net debt below twice EBITDA 0.4 x EBITDA
- Operating cash flow covers the profits of the last three years 582 m
- Return on capital at 15% or higher, or up versus two years ago 28.7%
- Insiders hold at least 10% or are net buyers 2.3%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
7/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 5.2%
- Exp. sales growth 3Y > 5% 4.7%
- EBIT growth 10Y > 5% 53.0%
- Exp. EBIT growth 3Y > 5% 12.2%
- Net debt < 4x EBIT 0.5x
- EBIT positive, 10Y straight 9
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% 36.1%
- ROCE > 15% 28.7%
- Expected return > 10% 19.1%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Lipesky Scott D. | EVP and COO | Sell | 2,000 | 146.82 | 293,640 |
| Aug 28, 2026 | Rust Jay | EVP, Chief HR Officer | Sell | 5,000 | 147.50 | 737,500 |
| Aug 28, 2026 | Robinson Kenneth B. | Director | Sell | 800 | 149.69 | 119,752 |
| Aug 28, 2026 | Lipesky Scott D. | EVP and COO | Sell | 5,000 | 149.00 | 745,000 |
| Aug 28, 2026 | Henchel Gregory J | EVP, Chief Legal Off & Secy | Sell | 30,000 | 146.65 | 4,399,500 |
| Aug 10, 2026 | Lipesky Scott D. | EVP and COO | Sell | 10,000 | 115.00 | 1,150,000 |
| Aug 4, 2026 | Lipesky Scott D. | EVP and COO | Sell | 10,000 | 110.00 | 1,100,000 |
| Jul 28, 2026 | Lipesky Scott D. | EVP and COO | Sell | 10,000 | 105.00 | 1,050,000 |
| Jul 16, 2026 | Lipesky Scott D. | EVP and COO | Sell | 10,000 | 100.00 | 1,000,000 |
The company
About the Company
Abercrombie & Fitch Co. ist über ihre Tochtergesellschaften als Omnichannel-Einzelhändler in Amerika, Europa, dem Nahen Osten, Afrika und im asiatisch-pazifischen Raum tätig.
- CEO Insider Trades (12 Mo.)
- selling own stock
- Employees
- 6,600
- Headquarters
- New Albany, OH
- Address
- 6301 Fitch Path, 43054 New Albany, United States
- Phone
- 614 283 6500
- Website
- corporate.abercrombie.com
- IPO Date
- 09/25/1996
- ISIN
- US0028962076
- Stock Split
- 2:1 on 06/16/1999
Management
| Name | Title | Birth Year |
|---|---|---|
| Fran Horowitz | CEO & Director | 1964 |
| Robert J. Ball | CFO & Executive VP | 1980 |
| Scott D. Lipesky | Executive VP & COO | 1975 |
| Samir Desai | Executive VP and Chief Digital & Technology Officer | 1981 |
| Gregory J. Henchel J.D. | Executive VP, Chief Legal Officer & Corporate Secretary | 1968 |
| Joseph Frericks | Group VP of Finance, Corporate Controller & Principal Accounting Officer | 1978 |
| Mohit Gupta | Vice President of Investor Relations | – |
| Kate Wagner | Vice President of Corporate Communications | – |
| Jay Rust | Executive VP & Chief Human Resources Officer | 1987 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 08/26/2026 ABERCROMBIE & FITCH CO /DE/ (ANF): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
- 08/20/2026 ABERCROMBIE & FITCH CO /DE/ (ANF): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.